Literature DB >> 36180755

Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes.

Jeffrey A Wesson1,2, Roman Zenka3, Jody Lulich4, Jessica Eisenhauer5, Carley Davis6,7.   

Abstract

Despite its critical nature, the role of matrix in calcium oxalate stone formation is poorly understood. The wide diversity of proteins comprising matrix has contributed to the ambiguity. This study compares the protein distributions measured by mass spectrometry in human calcium oxalate stone matrix to that observed in cat stone matrix, because cats share many clinical characteristics of their stone disease with humans. The observed protein distributions were analyzed in the context of a recent model based on the aggregation of strongly anionic and strongly cationic proteins which includes selective adsorption of other proteins based on total charge. Matrix protein distributions shared many common features between species, including enrichment of both strongly anionic and strongly cationic proteins, increased total charge in matrix proteins compared to urine proteins, and a high degree of similarity of prominent strongly anionic proteins in the matrix of both species. However, there was weaker overlap of the specific dominant proteins in other regions of the net charge distribution. Collectively, these observations support the conceptual model where the strongly anionic proteins associate most strongly with the calcium oxalate crystal surfaces, while the other proteins associate with the strongly anionic proteins through non-specific, charge interactions with each other to create stones. Also, cats appear to be the best animal model of human stone disease identified to date based on these similarities.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Keywords:  Calcium oxalate; Kidney calculi; Nephrolithiasis; Urine proteome

Mesh:

Substances:

Year:  2022        PMID: 36180755     DOI: 10.1007/s00240-022-01363-w

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   2.861


  21 in total

1.  A case-control study of the effects of nephrolithiasis in cats with chronic kidney disease.

Authors:  Sheri J Ross; Carl A Osborne; Chalermpol Lekcharoensuk; Lori A Koehler; David J Polzin
Journal:  J Am Vet Med Assoc       Date:  2007-06-15       Impact factor: 1.936

2.  Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein.

Authors:  Pragasam Viswanathan; Jeffrey D Rimer; Ann M Kolbach; Michael D Ward; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urol Res       Date:  2011-01-13

3.  Evaluation for association between urolithiasis and chronic kidney disease in cats.

Authors:  Andréanne Cléroux; Kate Alexander; Guy Beauchamp; Marilyn Dunn
Journal:  J Am Vet Med Assoc       Date:  2017-04-01       Impact factor: 1.936

Review 4.  Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.

Authors:  Y Nakagawa
Journal:  Keio J Med       Date:  1997-03

5.  Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?

Authors:  Jeffrey A Wesson; Ann M Kolbach-Mandel; Brian R Hoffmann; Carley Davis; Neil S Mandel
Journal:  Urolithiasis       Date:  2019-04-16       Impact factor: 3.436

6.  Comparison of matrix proteins in different types of urinary stone by proteomic analysis using liquid chromatography-tandem mass spectrometry.

Authors:  Kiyoko Kaneko; Riei Kobayashi; Makoto Yasuda; Yoko Izumi; Tomoyo Yamanobe; Toru Shimizu
Journal:  Int J Urol       Date:  2012-04-11       Impact factor: 3.369

Review 7.  The role of macromolecules in the formation of kidney stones.

Authors:  Jeffrey D Rimer; Ann M Kolbach-Mandel; Michael D Ward; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2016-12-02       Impact factor: 3.436

Review 8.  Tamm-Horsfall glycoprotein and calcium nephrolithiasis.

Authors:  B Hess
Journal:  Miner Electrolyte Metab       Date:  1994

9.  Label-free proteomic methodology for the analysis of human kidney stone matrix composition.

Authors:  Frank A Witzmann; Andrew P Evan; Fredric L Coe; Elaine M Worcester; James E Lingeman; James C Williams
Journal:  Proteome Sci       Date:  2016-02-27       Impact factor: 2.480

Review 10.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.